{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:48:23Z","timestamp":1786996103676,"version":"build-2736575974"},"reference-count":253,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154684","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T22:54:24Z","timestamp":1689202464000},"page":"154684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["miRNAs orchestration of gallbladder cancer \u2013 Particular emphasis on diagnosis, progression and drug resistance"],"prefix":"10.1016","volume":"248","author":[{"given":"Reem K.","family":"Shahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Elkady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan M.","family":"Abdelmaksoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz B.","family":"Zewail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Elazazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Sobhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra","family":"Nomier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Elazazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Midan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassant O.","family":"Ziada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154684_bib1","series-title":"Gallbladder Cancer: Current Treatment Options","first-page":"3","article-title":"Gallbladder cancer: current treatment options and therapeutics","author":"Taghizadieh","year":"2023"},{"key":"10.1016\/j.prp.2023.154684_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1143600","article-title":"Recent advances of three-dimensional bioprinting technology in hepato-pancreato-biliary cancer models","volume":"13","author":"Zhuang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2023.154684_bib3","article-title":"Clinical epidemiology of gallbladder cancer in North-Central India and association of immunological markers, NLR, MLR and PLR in the diagnostic\/prognostic prediction of GBC","volume":"28","author":"Singh","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.prp.2023.154684_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1200\/GO.20.00122","article-title":"Cancer statistics, 2020: report from national cancer registry programme, India","volume":"6","author":"Mathur","year":"2020","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.prp.2023.154684_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12029-017-0008-9","article-title":"Expression analysis of survivin and XIAP in gallbladder cancer: a case-control study in Indo-Gangetic plain","volume":"49","author":"Dixit","year":"2018","journal-title":"J. Gastrointest. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154684_bib6","first-page":"31","article-title":"Gallbladder cancer: epidemiology and genetic risk associations, Chin","volume":"8","author":"Schmidt","year":"2019","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154684_bib7","article-title":"Genetic mutational analysis of \u03b2-catenin gene affecting GSK-3\u03b2 phosphorylation plays a role in gallbladder carcinogenesis: results from a case control study","volume":"23","author":"Dixit","year":"2020","journal-title":"Cancer Treat. Res. Commun."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib8","first-page":"5948","article-title":"Health related quality of life in patients of the gallbladder cancer with treatment","volume":"8","author":"Pandey","year":"2017","journal-title":"Int. J. Biol. Med. Res."},{"key":"10.1016\/j.prp.2023.154684_bib9","unstructured":"R.D. Rosen A. Sapra TNM classification, StatPearls [Internet] StatPearls Publ. 2022."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdu006","article-title":"A genetic model for gallbladder carcinogenesis and its dissemination","volume":"25","author":"Barreto","year":"2014","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma","volume":"15","author":"Zhu","year":"2010","journal-title":"oncologist"},{"key":"10.1016\/j.prp.2023.154684_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12029-015-9698-z","article-title":"Female sex hormone receptors in gallbladder cancer","volume":"46","author":"Saranga Bharathi","year":"2015","journal-title":"J. Gastrointest. Cancer"},{"issue":"7","key":"10.1016\/j.prp.2023.154684_bib13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"C. La Vecchia, Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer","volume":"5","author":"Rawla","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of gallbladder disease: cholelithiasis and cancer","volume":"6","author":"Stinton","year":"2012","journal-title":"Gut liver"},{"key":"10.1016\/j.prp.2023.154684_bib16","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1245\/s10434-020-08654-9","article-title":"The landmark series: gallbladder cancer","volume":"27","author":"Gamboa","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"44","key":"10.1016\/j.prp.2023.154684_bib17","doi-asserted-by":"crossref","first-page":"12653","DOI":"10.3748\/wjg.v21.i44.12653","article-title":"Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: an analysis of 42 cases","volume":"21","author":"Deng","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.prp.2023.154684_bib18","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.3390\/cancers12123670","article-title":"Current and new biomarkers for early detection, prognostic stratification, and management of gallbladder cancer patients","volume":"12","author":"Garc\u00eda","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07334-x","article-title":"Raised CA19\u20139 and CEA have prognostic relevance in gallbladder carcinoma","volume":"20","author":"Sachan","year":"2020","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/bjs.10415","article-title":"Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer","volume":"104","author":"Yamashita","year":"2017","journal-title":"J. Br. Surg."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41392-020-0162-6","article-title":"Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma","volume":"5","author":"Xue","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154684_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154684_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.134","article-title":"miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay\u2014a review","volume":"214","author":"Elrebehy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154684_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153886","article-title":"miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers","author":"El-Mahdy","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154684_bib26","article-title":"Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: a comprehensive review","author":"Ismail","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154684_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154222","article-title":"The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance-a focus on signaling pathways interplay","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154510","article-title":"The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance \u2013 a focus on signaling pathways interplay","volume":"246","author":"Hegazy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154053","article-title":"A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay","author":"Doghish","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154316","article-title":"miRNAs role in bladder cancer pathogenesis and targeted therapy: signaling pathways interplay-a review","author":"El-Mahdy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib31","article-title":"miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154371","article-title":"Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib33","article-title":"miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013an emphasis on the interaction of signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154411","article-title":"The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154424","article-title":"miRNAs as potential game-changers in melanoma: a comprehensive review","author":"Abd-Allah","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154437","article-title":"The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy","author":"Zaki","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121667","article-title":"An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer","author":"Fathi","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154684_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154438","article-title":"Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance-A review","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib39","article-title":"A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154439","article-title":"miRNAs as potential game-changers in renal cell carcinoma: future clinical and medicinal uses","volume":"245","author":"Elballal","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154457","article-title":"miRNAs as potential game-changers in head and neck cancer: future clinical and medicinal uses","author":"El-Mahdy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121697","article-title":"Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats","volume":"323","author":"Allam","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154684_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105195","article-title":"Impact of the mother's gut microbiota on infant microbiome and brain development","author":"Mady","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.prp.2023.154684_bib44","article-title":"The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154511","article-title":"miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay","author":"Elshaer","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154557","article-title":"miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11","author":"Elrebehy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib47","article-title":"miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154584","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer \u2013 A Focus on signaling pathways interplay","volume":"247","author":"Abulsoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib49","article-title":"miRNAs orchestration of salivary gland cancer- Particular emphasis on diagnosis, progression, and drug resistance","author":"Ahmed","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib50","article-title":"The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - A Focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154612","article-title":"miRNAs orchestration of testicular germ cell tumors - Particular emphasis on diagnosis, progression and drug resistance","author":"Elesawy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154665","article-title":"miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance","author":"El-Dakroury","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154375","article-title":"The role of miRNAs in liver diseases: Potential therapeutic and clinical applications","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib54","article-title":"miRNAs as potential game-changers in bone diseases: Future medicinal and clinical Uses","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154613","article-title":"miRNAs orchestration of cardiovascular diseases \u2013 Particular emphasis on diagnosis, and progression","volume":"248","author":"Elsakka","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154624","article-title":"The potential role of miRNAs in the pathogenesis of cardiovascular diseases \u2013 A focus on signaling pathways interplay","volume":"248","author":"Khidr","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154684_bib57","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.154684_bib58","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes, Metab. Syndr. Obes.: Targets Ther."},{"issue":"7","key":"10.1016\/j.prp.2023.154684_bib59","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients with Metabolic Syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.154684_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154684_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154512","article-title":"Long non-coding RNAs and rheumatoid arthritis: pathogenesis and clinical implications","author":"Elazazy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.prp.2023.154684_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123189","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications \u2013 a review","volume":"230","author":"Abdel Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154684_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib65","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab. Syndr.: Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.prp.2023.154684_bib66","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/cbin.11653","article-title":"miRNAs; a novel strategy for the treatment of COVID\u201019","volume":"45","author":"Ying","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.prp.2023.154684_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154684_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.prp.2023.154684_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.prp.2023.154684_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112681","article-title":"MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets","volume":"148","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154684_bib71","unstructured":"K.I. Eissa, M.M. Kamel, L.W. Mohamed, A.S. Doghish, R. Alnajjar, A.A. Al\u2010Karmalawy, A.E. Kassab, Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease, Drug Dev. Res."},{"key":"10.1016\/j.prp.2023.154684_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2015.99","article-title":"How microRNAs modify protein production","volume":"135","author":"Feig","year":"2015","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep05150","article-title":"Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues","volume":"4","author":"Guo","year":"2014","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"Lin","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib75","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1038\/s41598-019-40857-3","article-title":"Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p","volume":"9","author":"Goeppert","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib76","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3748\/wjg.v22.i5.1787","article-title":"MicroRNA aberrations: an emerging field for gallbladder cancer management","volume":"22","author":"Chandra","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.prp.2023.154684_bib77","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1078-0432.CCR-16-1676","article-title":"Emerging role of MicroRNAs as liquid biopsy biomarkers in gastrointestinal cancersmiRNAs as liquid biopsy biomarkers","volume":"23","author":"Shigeyasu","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-91804-0","article-title":"Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients","volume":"11","author":"Ueta","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154684_bib79","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2023.154684_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154183","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association","volume":"240","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond","author":"Abd El Fattah","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154684_bib82","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2022","journal-title":"Comput. Biol. Med"},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib83","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Non-coding RNA Res."},{"issue":"7014","key":"10.1016\/j.prp.2023.154684_bib84","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154684_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.prp.2023.154684_bib86","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"11","key":"10.1016\/j.prp.2023.154684_bib87","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154684_bib88","first-page":"1","article-title":"Regulation of microRNAs, miRNomics","author":"Ergin","year":"2022","journal-title":"Springer"},{"issue":"7149","key":"10.1016\/j.prp.2023.154684_bib89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.prp.2023.154684_bib90","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib91","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154684_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154567","article-title":"The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b\/ZEB1 axis","volume":"247","author":"Salman","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154570","article-title":"LncRNA NNT-AS1\/hsa-miR-485\u20135p\/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: a step toward ncRNA Precision","volume":"247","author":"El-Sheikh","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154509","article-title":"Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: a review","volume":"246","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154684_bib95","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","article-title":"Classical and noncanonical functions of miRNAs in cancers","volume":"38","author":"Dragomir","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.prp.2023.154684_bib96","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int J. Biol. Macromol."},{"issue":"7795","key":"10.1016\/j.prp.2023.154684_bib97","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib98","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat. Genet"},{"issue":"9","key":"10.1016\/j.prp.2023.154684_bib99","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2023.154684_bib100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib101","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2023.154684_bib102","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2023.154684_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","author":"Al-Noshokaty","year":"2022","journal-title":"J. Life Sci."},{"key":"10.1016\/j.prp.2023.154684_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120325","article-title":"Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players","volume":"292","author":"Rizk","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bj.2020.03.001","article-title":"The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness","volume":"43","author":"Wu","year":"2020","journal-title":"Biomed. J."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib106","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/cells8060528","article-title":"Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells","volume":"8","author":"Ullmann","year":"2019","journal-title":"Cells"},{"issue":"7043","key":"10.1016\/j.prp.2023.154684_bib107","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"nature"},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1261\/rna.5167604","article-title":"Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs","volume":"10","author":"Bohnsack","year":"2004","journal-title":"Rna"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib109","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1582-4934.2008.00520.x","article-title":"The molecular machines that mediate microRNA maturation","volume":"13","author":"Lau","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.prp.2023.154684_bib111","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nsmb.1630","article-title":"Structural determinants of miRNAs for RISC loading and slicer-independent unwinding","volume":"16","author":"Kawamata","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-5-29","article-title":"Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues","volume":"5","author":"Bandr\u00e9s","year":"2006","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010630","article-title":"Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer","volume":"5","author":"Hwang","year":"2010","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.prp.2023.154684_bib114","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/0008-5472.CAN-09-4620","article-title":"Downregulation of MicroRNA-200 in EBV-Associated Gastric CarcinomaDownregulation of miR-200 in EBV-Associated Gastric Carcinoma","volume":"70","author":"Shinozaki","year":"2010","journal-title":"Cancer Res."},{"issue":"28","key":"10.1016\/j.prp.2023.154684_bib115","doi-asserted-by":"crossref","first-page":"21496","DOI":"10.1074\/jbc.M109.083337","article-title":"MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression","volume":"285","author":"Zhou","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib116","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/jhg.2010.54","article-title":"Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population","volume":"55","author":"Srivastava","year":"2010","journal-title":"J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib117","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2012.01.018","article-title":"The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5. erbB2 mice","volume":"57","author":"Kitamura","year":"2012","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib118","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/cas.12463","article-title":"Micro RNA\u2010135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer","volume":"105","author":"Zhou","year":"2014","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib119","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3892\/ijo.2014.2360","article-title":"MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2","volume":"44","author":"Zhou","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2023.154684_bib120","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s13277-013-1207-z","article-title":"miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells","volume":"35","author":"Jin","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2023.154684_bib121","first-page":"1625","article-title":"Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma","author":"Peng","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2023.154684_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-13-156","article-title":"Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer","volume":"13","author":"Ma","year":"2014","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.541","article-title":"Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p","volume":"6","author":"Ma","year":"2015","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib124","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/or.2013.2443","article-title":"High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma","volume":"30","author":"Kono","year":"2013","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jhep.2013.04.034","article-title":"MiR-20a triggers metastasis of gallbladder carcinoma","volume":"59","author":"Chang","year":"2013","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib126","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1039\/C3MB70479C","article-title":"TGF-\u03b2 upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1","volume":"10","author":"Qiu","year":"2014","journal-title":"Mol. Biosyst."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib127","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.ygeno.2020.03.022","article-title":"Effect of scopoletin on phagocytic activity of U937-derived human macrophages: insights from transcriptomic analysis","volume":"112","author":"Alkorashy","year":"2020","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.prp.2023.154684_bib128","first-page":"845","article-title":"MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers","volume":"16","author":"Akao","year":"2006","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib129","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1093\/nar\/gkr1222","article-title":"MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer","volume":"40","author":"Hudson","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.prp.2023.154684_bib130","doi-asserted-by":"crossref","first-page":"E1388","DOI":"10.1210\/jc.2011-0345","article-title":"MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1\u03b1","volume":"96","author":"Leone","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib131","first-page":"1099","article-title":"Identification of novel molecular targets regulated by tumor suppressive miR-1\/miR-133a in maxillary sinus squamous cell carcinoma","volume":"39","author":"Nohata","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2023.154684_bib132","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1349-7006.2007.00618.x","article-title":"Downregulation of microRNAs\u2010143 and\u2010145 in B\u2010cell malignancies","volume":"98","author":"Akao","year":"2007","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-109","article-title":"Identification of differentially expressed microRNAs in human male breast cancer","volume":"10","author":"Lehmann","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154684_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.apmt.2022.101560","article-title":"Smart\/stimuli-responsive hydrogels: State-of-the-art platforms for bone tissue engineering","author":"El-Husseiny","year":"2022","journal-title":"Appl. Mater. Today"},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib135","first-page":"1849","article-title":"miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer","volume":"7","author":"Letelier","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib136","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbrc.2009.07.143","article-title":"MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer","volume":"388","author":"Crawford","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2023.154684_bib137","series-title":"Urologic Oncology: Seminars and Original Investigations","first-page":"434","article-title":"Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer","author":"Chiyomaru","year":"2012"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib138","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bbrc.2011.12.011","article-title":"Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine\/arginine-rich 9 (SRSF9\/SRp30c) in bladder cancer","volume":"417","author":"Yoshino","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2023.154684_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1423-0127-18-1","article-title":"MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells","volume":"18","author":"Wu","year":"2011","journal-title":"J. Biomed. Sci."},{"issue":"20","key":"10.1016\/j.prp.2023.154684_bib140","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.febslet.2011.08.052","article-title":"miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line","volume":"585","author":"Wang","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2023.154684_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2022.101972","article-title":"Carnosine and crocin ameliorate oxidative stress in rats with rhabdomyolysis-induced acute kidney injury through upregulating HO-1 gene expression","volume":"49","author":"El-Ashmawy","year":"2022","journal-title":"Food Biosci."},{"issue":"11","key":"10.1016\/j.prp.2023.154684_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078428","article-title":"Metastasis suppressor microRNA-335 targets the formin family of actin nucleators","volume":"8","author":"Lynch","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154684_bib143","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11010-013-1786-4","article-title":"miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells","volume":"384","author":"Wang","year":"2013","journal-title":"Mol. Cell. Biochem."},{"issue":"7291","key":"10.1016\/j.prp.2023.154684_bib144","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"nature"},{"issue":"4","key":"10.1016\/j.prp.2023.154684_bib145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/epi.11.70","article-title":"Chromatin: a key player in complex gene regulation and future cancer therapeutics","volume":"3","author":"Roukos","year":"2011","journal-title":"Epigenomics"},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib146","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/onc.2012.55","article-title":"MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma","volume":"32","author":"Boll","year":"2013","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.prp.2023.154684_bib147","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/abbs\/gmt113","article-title":"Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly","volume":"45","author":"Zhang","year":"2013","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib148","first-page":"1217","article-title":"Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5, blood","volume":"111","author":"Chen","year":"2008","journal-title":"J. Am. Soc. Hematol."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib149","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3892\/or.2013.2685","article-title":"microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma","volume":"30","author":"Ling","year":"2013","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3892\/mmr.2014.2744","article-title":"microRNA\u2011155 promotes the proliferation of prostate cancer cells by targeting annexin 7","volume":"11","author":"Cai","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.prp.2023.154684_bib151","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1742-4658.2012.08519.x","article-title":"MicroRNA\u2010182 targets cAMP\u2010responsive element\u2010binding protein 1 and suppresses cell growth in human gastric adenocarcinoma","volume":"279","author":"Kong","year":"2012","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib152","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biocel.2012.12.010","article-title":"The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation","volume":"45","author":"Xu","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prp.2023.154684_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-014-0473-z","article-title":"MiR-183\/-96\/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration","volume":"16","author":"Li","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2023.154684_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0225-z","article-title":"Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer","volume":"31","author":"Chen","year":"2014","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib155","first-page":"3498","article-title":"Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib156","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.0808263106","article-title":"Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor","volume":"106","author":"Segura","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib157","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ijc.28056","article-title":"MiR\u2010182 and miR\u2010203 induce mesenchymal to epithelial transition and self\u2010sufficiency of growth signals via repressing SNAI2 in prostate cells","volume":"133","author":"Qu","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib158","first-page":"1014","article-title":"Implication of miRNAs in the pathogenesis of gallbladder cancer","volume":"2","author":"Letelier","year":"2015","journal-title":"Austin Biomark. Diagn."},{"issue":"4","key":"10.1016\/j.prp.2023.154684_bib159","article-title":"miR\u2011642 serves as a tumor suppressor in hepatocellular carcinoma by regulating SEMA4C and p38 MAPK signaling pathway","volume":"20","author":"Yu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2023.154684_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01483-6","article-title":"MiR-145-5p suppresses the proliferation, migration and invasion of gastric cancer epithelial cells via the ANGPT2\/NOD_LIKE_RECEPTOR axis","volume":"20","author":"Zhou","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib161","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1002\/jcp.27525","article-title":"miR\u2010145\u20135p affects the differentiation of gastric cancer by targeting KLF5 directly","volume":"234","author":"Zhou","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.prp.2023.154684_bib162","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1096\/fj.201902555R","article-title":"MicroRNA\u2010145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6, The","volume":"34","author":"Hsu","year":"2020","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib163","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41419-017-0258-2","article-title":"miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K\/AKT pathway in gallbladder carcinoma","volume":"9","author":"Jin","year":"2018","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib164","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2013.2913","article-title":"Epigenetic regulation and cancer","volume":"31","author":"Chen","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2023.154684_bib165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0029-1237423","article-title":"Epigenetics: definition, mechanisms and clinical perspective","author":"Dupont","year":"2009","journal-title":"Semin. Reprod. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib166","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.4103\/0971-5916.191792","article-title":"Epigenetic regulation of APC in the molecular pathogenesis of gallbladder cancer","volume":"143","author":"Tekcham","year":"2016","journal-title":"Indian J. Med. Res."},{"issue":"18","key":"10.1016\/j.prp.2023.154684_bib167","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1158\/1078-0432.CCR-04-0579","article-title":"Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis","volume":"10","author":"Takahashi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154684_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-15-1","article-title":"Radioactive 125 I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway","volume":"15","author":"Tian","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib169","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.prp.2023.154684_bib170","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1007\/s13277-015-3412-4","article-title":"MicroRNA signatures in total peripheral blood of gallbladder cancer patients","volume":"36","author":"Li","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2023.154684_bib171","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijsu.2018.03.053","article-title":"DNA methylation as an epigenetic regulator of gallbladder cancer: an overview","volume":"53","author":"Muhammad","year":"2018","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.prp.2023.154684_bib172","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biocel.2019.04.001","article-title":"MiR-9 promotes synovial sarcoma cell migration and invasion by directly targeting CDH1","volume":"112","author":"Xu","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib173","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/15384101.2021.1874694","article-title":"miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients","volume":"20","author":"Jiang","year":"2021","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.prp.2023.154684_bib174","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.154684_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154684_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib177","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.154684_bib178","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"46","key":"10.1016\/j.prp.2023.154684_bib179","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.prp.2023.154684_bib180","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: Antibacterial, antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib181","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib182","first-page":"1849","article-title":"miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer","volume":"7","author":"Letelier","year":"2014","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib183","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/cdd.2016.146","article-title":"MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway","volume":"24","author":"Shu","year":"2017","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib184","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41419-018-0444-x","article-title":"MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7","volume":"9","author":"Ye","year":"2018","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3892\/ol.2021.12461","article-title":"MicroRNA\u2011182 promotes epithelial\u2011mesenchymal transition by targeting FOXN3 in gallbladder cancer","volume":"21","author":"Zhang","year":"2021","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib186","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41417-020-00252-x","article-title":"Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression","volume":"28","author":"Ji","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib187","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12510","article-title":"MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma","volume":"51","author":"Chen","year":"2018","journal-title":"Cell Prolif."},{"key":"10.1016\/j.prp.2023.154684_bib188","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.683725","article-title":"Downregulation of miR-181b-5p inhibits the viability, migration, and glycolysis of gallbladder cancer by upregulating PDHX under hypoxia","volume":"11","author":"Qin","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib189","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mc.22799","article-title":"LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma","volume":"57","author":"He","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"11","key":"10.1016\/j.prp.2023.154684_bib190","first-page":"2448","article-title":"MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ","volume":"6","author":"Huang","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"16","key":"10.1016\/j.prp.2023.154684_bib191","doi-asserted-by":"crossref","first-page":"22339","DOI":"10.18632\/oncotarget.7970","article-title":"miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK\/Erk and Smad pathways in gallbladder carcinoma","volume":"7","author":"Bao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154684_bib192","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.2147\/OTT.S229614","article-title":"Downregulation of miR-575 Inhibits the Tumorigenesis of Gallbladder Cancer via Targeting p27 Kip1","volume":"13","author":"Qin","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib193","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3892\/mmr.2015.3461","article-title":"MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor","volume":"12","author":"Cai","year":"2015","journal-title":"Mol. Med Rep."},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib194","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/cas.12463","article-title":"MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer","volume":"105","author":"Zhou","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2023.154684_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00669","article-title":"Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer","volume":"9","author":"L\u00f3pez-Urrutia","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib196","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.541","article-title":"Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p","volume":"6","author":"Ma","year":"2015","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib197","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-019-0947-9","article-title":"Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143\/HK2 axis in gallbladder cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154684_bib198","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.2147\/OTT.S236350","article-title":"Long Noncoding RNA NEAT1 Upregulates Survivin and Facilitates Gallbladder Cancer Progression by Sponging microRNA-335","volume":"13","author":"Yang","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"9","key":"10.1016\/j.prp.2023.154684_bib199","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20194509","article-title":"Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.178","article-title":"miR-218-5p restores sensitivity to gemcitabine through PRKCE\/MDR1 axis in gallbladder cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib201","doi-asserted-by":"crossref","first-page":"43109","DOI":"10.1038\/srep43109","article-title":"miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib202","doi-asserted-by":"crossref","first-page":"10553","DOI":"10.1007\/s13277-016-4957-6","article-title":"miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1","volume":"37","author":"Zhan","year":"2016","journal-title":"Tumor Biol."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib203","first-page":"953","article-title":"Protective effect of proanthocyanidins on nephrotoxicity induced by antitumor dose of cisplatin in ehrlich solid tumor-bearing mice","volume":"40","author":"Salman","year":"2014","journal-title":"Arab. J. Lab. Med"},{"issue":"50","key":"10.1016\/j.prp.2023.154684_bib204","doi-asserted-by":"crossref","first-page":"83060","DOI":"10.18632\/oncotarget.13067","article-title":"MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"38","key":"10.1016\/j.prp.2023.154684_bib205","doi-asserted-by":"crossref","first-page":"62364","DOI":"10.18632\/oncotarget.11634","article-title":"miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.prp.2023.154684_bib206","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3390\/biom11121847","article-title":"Reiterating the emergence of noncoding RNAs as regulators of the critical hallmarks of gall bladder cancer","volume":"11","author":"Rana","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib207","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1751-2980.12966","article-title":"Novel biomarkers for the diagnosis and prognosis of gallbladder cancer","volume":"22","author":"Lin","year":"2021","journal-title":"J. Dig. Dis."},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib208","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw202","article-title":"Adjuvant therapy for resected gallbladder cancer: analysis of the National Cancer Data Base","volume":"109","author":"Mantripragada","year":"2017","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.prp.2023.154684_bib209","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000098","article-title":"Development and validation of a nomogram for early detection of malignant gallbladder lesions","volume":"10","author":"Chen","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023584","article-title":"Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer","volume":"6","author":"Shigehara","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib211","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med."},{"issue":"2022 (","key":"10.1016\/j.prp.2023.154684_bib212","article-title":"MRNA profiling involved in triggering of STAT1 with regulatory involvement of IRF7, PTPRF, and miR-145p in patients suffering from gall bladder Carcinoma","author":"Zhao","year":"2022","journal-title":"J. Healthc. Eng."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-022-03394-8","article-title":"Identification of invasion-metastasis associated MiRNAs in gallbladder cancer by bioinformatics and experimental validation","volume":"20","author":"Cao","year":"2022","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.prp.2023.154684_bib214","article-title":"The role of MiRNA\u2010433 in malignant tumors of digestive tract as tumor suppressor","volume":"5","author":"Tang","year":"2022","journal-title":"Cancer Rep."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib215","first-page":"518","article-title":"Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma","volume":"21","author":"Lv","year":"2017","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib216","first-page":"315","article-title":"miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression, Artificial Cells","volume":"48","author":"Zhang","year":"2020","journal-title":"Nanomed., Biotechnol."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib217","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41419-018-0444-x","article-title":"MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7","volume":"9","author":"Ye","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.prp.2023.154684_bib218","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3748\/wjg.v26.i9.933","article-title":"Exosomal miR-182 regulates the effect of RECK on gallbladder cancer","volume":"26","author":"Zheng","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.prp.2023.154684_bib219","doi-asserted-by":"crossref","first-page":"G670","DOI":"10.1152\/ajpgi.00055.2019","article-title":"Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4","volume":"317","author":"Niu","year":"2019","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib220","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317692249","article-title":"MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer","volume":"39","author":"Yang","year":"2017","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib221","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/cdd.2016.146","article-title":"MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway","volume":"24","author":"Shu","year":"2017","journal-title":"Cell Death Differ."},{"issue":"22","key":"10.1016\/j.prp.2023.154684_bib222","first-page":"9829","article-title":"MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib223","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/jcp.29126","article-title":"Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers","volume":"235","author":"Aghebati\u2010Maleki","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.prp.2023.154684_bib224","article-title":"Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant\/type 2 diabetic rat model","volume":"79","author":"El-Dakroury","year":"2023","journal-title":"Rat. Model"},{"key":"10.1016\/j.prp.2023.154684_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121303","article-title":"Famotidine-loaded solid self-nanoemulsifying drug delivery system demonstrates exceptional efficiency in amelioration of pepticulcer","volume":"611","author":"El-Dakroury","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.prp.2023.154684_bib226","doi-asserted-by":"crossref","unstructured":"M.B. Zewail S.A. El-Gizawy M.A. Osman Y.A. Haggag Technol., Prep. Vitr. Charact. a Nov. self-nano \u00c9muls. Drug Deliv. Syst. a fixed-dose Comb. candesartan cilexetil hydrochlorothiazide 61 2021 102320.","DOI":"10.1016\/j.jddst.2021.102320"},{"issue":"9","key":"10.1016\/j.prp.2023.154684_bib227","doi-asserted-by":"crossref","first-page":"14744","DOI":"10.1021\/acsnano.1c04570","article-title":"Nanomaterial-facilitated cyclin-dependent kinase 7 inhibition suppresses gallbladder cancer progression via targeting transcriptional addiction","volume":"15","author":"Huang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.prp.2023.154684_bib228","first-page":"49","article-title":"Gallic acid loaded PEO-core\/zein-shell nanofibers for chemopreventive action on gallbladder cancer cells","volume":"119","author":"Acevedo","year":"2018","journal-title":"Eur.\u00a0J.\u00a0Pharm.\u00a0Sci."},{"key":"10.1016\/j.prp.2023.154684_bib229","doi-asserted-by":"crossref","unstructured":"W.H.J.Or Park Gallic acid induces HeLa cell death via increasing GSH depletion rather than ROS levels 37 2 2017 1277 1283.","DOI":"10.3892\/or.2016.5335"},{"key":"10.1016\/j.prp.2023.154684_bib230","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.biopha.2016.10.048","article-title":"Gallic acid reduces cell growth by induction of apoptosis and reduction of IL-8 in HepG2 cells","volume":"84","author":"Lima","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154684_bib231","doi-asserted-by":"crossref","unstructured":"S. Shahrzad K. Aoyagi A. Winter A. Koyama I.J.T.Jon Bitsch Pharmacokinet. Gall. Acid. its Relat. Bioavailab. tea Healthy Hum. 131 4 2001 1207 1210.","DOI":"10.1093\/jn\/131.4.1207"},{"key":"10.1016\/j.prp.2023.154684_bib232","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1208\/s12249-013-9991-8","article-title":"The gallic acid-phospholipid complex improved the antioxidant potential of gallic acid by enhancing its bioavailability","volume":"14","author":"Bhattacharyya","year":"2023","journal-title":"AAPS Pharm Sci Tech"},{"issue":"1","key":"10.1016\/j.prp.2023.154684_bib233","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acsnano.8b06400","article-title":"Glutathione-responsive prodrug nanoparticles for effective drug delivery and cancer therapy","volume":"13","author":"Ling","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.prp.2023.154684_bib234","doi-asserted-by":"crossref","unstructured":"Y. Liu, X. Zhi, M. Yang, J. Zhang, L. Lin, X. Zhao, W. Hou, C. Zhang, Q. Zhang, F.J.T. Pan, Tumor-triggered drug release from calcium carbonate-encapsulated gold nanostars for near-infrared photodynamic\/photothermal combination antitumor therapy 7 6 2017 1650.","DOI":"10.7150\/thno.17602"},{"key":"10.1016\/j.prp.2023.154684_bib235","doi-asserted-by":"crossref","unstructured":"X. Zhao Z. Yuan L. Yildirimer J. Zhao Z.Y. Lin Z. Cao G. Pan W.J.S. Cui Tumor Control. Drug Release Electro Fibers Using Inorg. caps Inhib. Cancer relapse 11 34 2015 4284 4291.","DOI":"10.1002\/smll.201500985"},{"key":"10.1016\/j.prp.2023.154684_bib236","doi-asserted-by":"crossref","unstructured":"S.C. Maom Lu Regul. glutathione Synth. 30 1\u20132 2009 42 59.","DOI":"10.1016\/j.mam.2008.05.005"},{"key":"10.1016\/j.prp.2023.154684_bib237","article-title":"Efficient delivery of BRD4 inhibitor by glutathione-sensitive nanoparticle to suppress gallbladder cancer through inhibiting NF-\u03baB signaling","volume":"21","author":"Xu","year":"2020","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.prp.2023.154684_bib238","doi-asserted-by":"crossref","unstructured":"J. Zou C. Jiang X. Li T. Zhong S. Wang B. Wang D. Zhang J.-N. Hao Y. Cao M. Guan Redox-responsive Eng. Hybrid. Nanomed. Gall. Cancer Ther. via hyaluronic Acid. Deplet. 30 2023 101707.","DOI":"10.1016\/j.apmt.2022.101707"},{"issue":"10","key":"10.1016\/j.prp.2023.154684_bib239","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/acs.nanolett.1c00209","article-title":"Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for cancer immunotherapy","volume":"21","author":"Wei","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.prp.2023.154684_bib240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.genrep.2016.09.001","article-title":"Matrix metalloproteinase (MMP)-2\u20131306\u2009C> T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients","volume":"5","author":"Elkady","year":"2016","journal-title":"Gene Rep."},{"key":"10.1016\/j.prp.2023.154684_bib241","doi-asserted-by":"crossref","unstructured":"H. Zhou Z. Fan J. Deng P.K. Lemons D.C. Arhontoulis W.B. Bowne H.J.Nl Cheng Hyaluronidase Embed. nanocarrier PEG Shell Enhanc. Tumor penetration highly Effic. Antitumor Effic. 16 5 2016 3268 3277.","DOI":"10.1021\/acs.nanolett.6b00820"},{"key":"10.1016\/j.prp.2023.154684_bib242","doi-asserted-by":"crossref","unstructured":"M. Tarannum J. Vivero-Escoto Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment Adv. Drug Deliv. Rev. 2022 114357.","DOI":"10.1016\/j.addr.2022.114357"},{"key":"10.1016\/j.prp.2023.154684_bib243","first-page":"192","article-title":"Breaching Castle walls: hyaluronan Deplet. a Ther","volume":"5","author":"Fio Shepard","year":"2015","journal-title":"Approach Cancer Ther"},{"key":"10.1016\/j.prp.2023.154684_bib244","first-page":"33","article-title":"Bortezomib: Protea Inhib. Eff.","volume":"57","author":"Richardson","year":"2006","journal-title":"Anticancer Ther."},{"issue":"6","key":"10.1016\/j.prp.2023.154684_bib245","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.2009.23.8220","article-title":"Bortezomib Or. dexamethasone Prim. Syst. (Light chain) amyloidosis","volume":"28","author":"Kastritis","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib246","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.3390\/ijms24087513","article-title":"Impact of adipose tissue depot harvesting site on the multilineage induction capacity of male rat adipose-derived mesenchymal stem cells: an in vitro study","volume":"24","author":"El-Husseiny","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.prp.2023.154684_bib247","article-title":"Bortezomib\u2010Encapsulated Dual Responsive Copolym","volume":"9","author":"Chen","year":"2022","journal-title":"Nanopart. Gall. Cancer Target. Ther."},{"key":"10.1016\/j.prp.2023.154684_bib248","unstructured":"J. Verma C. Warsame R.K. Seenivasagam N.K. Katiyar E. Aleem S.J.C. Goel M. Reviews Nanopart. -Mediat. Cancer Cell Ther.: Basic Sci. Clin. Appl. 2023 1 27."},{"issue":"17","key":"10.1016\/j.prp.2023.154684_bib249","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1039\/C4CS00322E","article-title":"Emerging translational research on magnetic nanoparticles for regenerative medicine","volume":"44","author":"Gao","year":"2015","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.prp.2023.154684_bib250","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020364","article-title":"Application of magnetic nanoparticles for rapid detection and in situ diagnosis in clinical oncology","volume":"14","author":"Onishi","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.prp.2023.154684_bib251","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jso.25285","article-title":"Diagnostic value of near-infrared or fluorescent indocyanine green guided sentinel lymph node mapping in gastric cancer: A systematic review and meta-analysis","volume":"118","author":"He","year":"2018","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1016\/j.prp.2023.154684_bib252","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ejso.2017.05.026","article-title":"A Pilot Study Assess. Infrared Laparosc. indocyanine Green. (ICG) intraoperative Sentin. Lymph. node Mapp. Early Colon Cancer","volume":"43","author":"Currie","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.prp.2023.154684_bib253","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248531","article-title":"Intraoperative laparoscopic detection of sentinel lymph nodes with indocyanine green and superparamagnetic iron oxide in a swine gallbladder cancer model","volume":"16","author":"Mihara","year":"2021","journal-title":"PLoS One"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:02:09Z","timestamp":1774411329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":253,"alternative-id":["S0344033823003849"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154684","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNAs orchestration of gallbladder cancer \u2013 Particular emphasis on diagnosis, progression and drug resistance","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154684"}}